| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
2 companies
Goncalves Joana is a Chief Medical Officer at Tvardi Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 7,000 | $66.12 | $462,829.56 | -6.3% | - | - | |
| Jan 15, 2026 | ORKA Oruka Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 7,000 | $31.81 | $222,704.45 | -55.3% | +83.3% | - | |
| Dec 19, 2025 | ORKA Oruka Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 7,000 | $30.61 | $214,293.02 | -25.8% | +21.9% | - | |
| Apr 5, 2024 | TVRD Tvardi Therapeutics, Inc. | Chief Medical Officer | Sell | 2,753 | $0.83 | $2,284.99 | -4.9% | -67.4% | -54.3% | |
| Feb 29, 2024 | TVRD Tvardi Therapeutics, Inc. | Chief Medical Officer | Sell | 3,293 | $0.89 | $2,930.77 | -5.5% | -27.4% | -53.1% | |
| Jun 23, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Medical Officer | Sell | 2,723 | $3.51 | $9,557.73 | -4.8% | -50.6% | -92.0% | |
| Apr 4, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Medical Officer | Sell | 2,481 | $4.91 | $12,181.71 | -4.2% | -38.8% | -80.9% | |
| Mar 3, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Medical Officer | Sell | 6,221 | $9.71 | $60,405.91 | -9.6% | -69.9% | -90.8% | |
| Feb 16, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Medical Officer | Sell | 2,265 | $10.20 | $23,103.00 | -3.4% | -59.7% | -94.0% | |
| Feb 8, 2023 | TVRD Tvardi Therapeutics, Inc. | Chief Medical Officer | Sell | 7,770 | $0.53 | $4,118.10 | -11.6% | -64.2% | -95.5% |